Anna Conen
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 6
- Antifungal resistance and susceptibility 5
- Microbiology top 5%
- Epidemiology top 10%
- Infective Endocarditis Diagnosis and Management 7
- Sepsis Diagnosis and Treatment 5
- Fungal Infections and Studies 5
- Virology top 10%
-
- Streptococcal Infections and Treatments 6
-
- Infectious Diseases and Tuberculosis 5
-
- Respiratory Support and Mechanisms 4
- Co-authors
- Andrej TrampužManuel BattegayUrsula FlückigerLaura N. WaltiChristoph A. FuxAdrian MerloPeter VajkoczyPhilipp Schüetz
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Anna Conen
51 papers receiving 994 citations
Peers
Comparison fields: 5 of 101
- Infectious Diseases 409
- Microbiology 119
- Epidemiology 436
- Virology 56
- Critical Care and Intensive Care Medicine 45
Countries citing papers authored by Anna Conen
This map shows the geographic impact of Anna Conen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Conen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Conen more than expected).
Fields of papers citing papers by Anna Conen
This network shows the impact of papers produced by Anna Conen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Conen. The network helps show where Anna Conen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna Conen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 9 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 3 | |
| 7 | 2021 | 5 | |
| 8 | 2021 | 21 | |
| 9 | 2021 | 13 | |
| 10 | 2021 | 22 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 4 | |
| 13 | 2020 | 12 | |
| 14 | 2020 | 40 | |
| 15 | 2020 | 7 | |
| 16 | 2020 | 52 | |
| 17 | 2019 | 15 | |
| 18 | 2019 | 51 | |
| 19 | 2015 | 16 | |
| 20 | 2010 | 30 |
About Anna Conen
Anna Conen is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Epidemiology, having authored 52 papers that have together received 1.0k indexed citations. Recurring topics across this work include Infective Endocarditis Diagnosis and Management (7 papers), COVID-19 Clinical Research Studies (6 papers), Streptococcal Infections and Treatments (6 papers), Antifungal resistance and susceptibility (5 papers), Infectious Diseases and Tuberculosis (5 papers), Sepsis Diagnosis and Treatment (5 papers), Fungal Infections and Studies (5 papers) and Respiratory Support and Mechanisms (4 papers). The work is most often cited by research in Infectious Diseases (409 citations), Microbiology (119 citations) and Epidemiology (436 citations). Anna Conen has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Andrej Trampuž, Manuel Battegay, Ursula Flückiger, Laura N. Walti, Christoph A. Fux, Adrian Merlo, Peter Vajkoczy, Philipp Schüetz, Beat Müeller and Sebastian Haubitz. Their work appears in journals such as Swiss Medical Weekly, Infection, Clinical Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.